SPINK1 and prostate cancer: Furthermore, the phenomenon was substantiated by another group showing the SPINK1-dependent increase in chemoresistance in the prostate cancer cell lines PC3, DU145, LNCaP and M12 treated with AG-1478 or cetuximab [9].